Abstract. Aberrant DNA methylation and histone deacetylation participate in cancer development and progression; hence, their reversal by inhibitors of DNA methylation and histone deacetylases is a promising cancer therapy. Experimental data demonstrate that these inhibitors in combination do not only show synergy in antitumor effects but also in whole genome global expression. Ten pairs of pre-and posttreatment cervical tumor samples were analyzed by microarray analysis. Treatment for seven days with hydralazine and valproate (HV) in patients up-regulated 964 genes. The two pathways possessing the highest number of up-regulated genes comprised the ribosome protein and the oxidative phosphorylation pathways, followed by MAPK signaling, tight junction, adherens junction, actin cytoskeleton, cell cycle, focal adhesion, apoptosis, proteasome, Wnt signaling, and antigen processing and presentation pathways. Upregulated genes by HV, clustered with down-regulated genes in untreated primary cervical carcinomas and were more alike as compared with up-regulated genes from untreated patients in terms of gene ontology. Increased acetylated p53 was also observed. Epigenetic therapy with HV leads to gene reactivation in primary tumors of cervical cancer patients as well as protein acetylation. A number of these reactivated genes have a definitive role as a tumor suppressors. The global expression pattern induced by HV suggests this therapy has an impact on pathways related to energy production which may promote apoptosis.
Introduction
DNA methylation (DNMT) and histone deacetylase inhibitors (HDAC) exert their antitumor effects by inhibiting cell proliferation, metastases, angiogenesis, and by inducing cell differentiation and/or apoptosis, as well as by increasing chemotherapy cytotoxicity (1) (2) (3) (4) (5) . Further, these epigenetic drugs are radiosensitizers (6) (7) (8) .
The rationale for utilizing these epigenetic drugs for cancer treatment has relied on the theory that reversing epigenetic aberrations would turn-on tumor suppressor genes and consequently exert antitumor effects. Most of this knowledge however, has been gained in experimental systems by candidate-gene approach which is a biased method. On the contrary, epigenomic pharmacological reactivation strategy in either cancer cell lines or cancer patients followed by global gene expression analysis may identify up-regulated genes in an unbiased manner (9) .
Synergy between DNMT and HDAC inhibitors on gene re-expression at a global scale is already known (10) indicating that the reversal of these two epigenetic factors synergizes gene re-expression (11) . We have shown that in the SW480 colon cancer cell line, the combination of hydralazine and valproic acid has a synergistic effect on gene reactivation (5) .
We recently completed a proof-of-principle study of epigenetic therapy (12) with the DNA methylation and HDAC inhibitors hydralazine and valproate (HV) respectively, added to neoadjuvant doxorubicin cyclophosphamide for locally advanced breast cancer in which we demonstrate global DNA hypomethylation and HDAC activity inhibition in the peripheral blood of patients, as well as gene up-regulation of >1,000 genes in primary breast tumors after 7 days of treatment with HV (12) . However, because of the technical difficulties for taking post-treatment tumor samples from the breast, these data emerged from the analysis of only a pair of pre-and post-treatment samples and 2 additional pre-treat-ment samples. Here, we extended those observations in a trial performed in cervical cancer patients. Nucleic acid extraction. RNA from tumors was obtained using the TriReagent RNA extraction kit (Gibco-BRL, Grand Island, NY, USA) following manufacturer's instructions.
Microarray analysis. Target preparation, hybridization, posthybridization, processing, scanning, and normalization were conducted essentially as described (12) . Statistical analysis of microarray data was carried out as follows: log 2 gene expression ratios were filtered in order to obtain genes with an absolute ratio >1. Gene set was analyzed by means of significance analysis of microarrays (SAM), then obtaining statistical altered genes with a false discovery rate (FDR) <5%. Significant genes were loaded onto WebGestalt (14) , which has the potential to organize and visualize gene sets within the context of Kyoto Encyclopedia of Genes and Genomes (KEGG) (http://www.genome.ad.jp/kegg) biochemical pathways.
Expression profiles comparison.
We compared the expression profiles derived from a previous report (15) in which a high-throughput transcriptional analysis in cervical cancer (CC) was done against the HV-induced genes found in the present report. Hence, we compared three expression profiles; HV with 964 significant genes; Up-CC with 1004 overexpressed and Down-CC with 1066 down-regulated genes. Then, ratios were normalized against the absolute media of all expression profiles; obtaining a normalized profile of three different biological entities: normal cervix (represented by absolute value of Down-CC expression ratios) cervical cancer (represented by Up-CC) and cervical cancer treated with epigenetic drugs (represented by HV). In order to look for differences in three profiles described above an initial hierarchical cluster analysis was performed using Spearman rank correlation as similarity metrics and average linkage as the clustering method. To search for differences in biological processes at gene ontology (GO) terms in three expression profiles (HV, Up-CC and Down-CC) we employed FatiGO data mining software, that is an open-access web based program to find differential distributions of biological terms between different groups of genes (16) . Retrieved biological processes were taken into account only if adjusted p-values were <0.01. Finally, significantly GO biological processes associated terms were graphed.
CpG islands content.
We sought for occurrence of CpG islands in genes shared in Down-CC and HV. A 1 kB upstream sequence of transcriptional start site for each gene was submitted to Genome Table Browser (http://genome.ucsc.edu/ cgi-bin/hgTables) and CpG islands were searched according to definition from Gardiner-Garden and Frommer (17) . Accordingly, a CpG island is defined as a DNA region at least 200 bases long (in our case we used 1000 bp) with a G+C content >50% and an observed/expected CpG ratio ≥0.6.
RT-PCR.
Primers for NDUFA13 comprised the following: forward 5'aatgcaagaaccaaggcgagtcac3' and reverse 5'aggcat gtcctgcttcacctttga3'. Annealing temperature was 60˚C for 35 cycles. Products were electrophoresed and visualized under ultraviolet light.
Immunohistochemistry of cervical cancer biopsies. Basal and post-treatment (biopsy at day 8, before starting chemoradiation) biopsies were analyzed by immunohistochemistry for NDUFA13 and acetylated p53 as follows: 4-μm sections of triplicate tissue microarray (pre-and post-treatment with HV) blocks were cut and transferred to adhesive-coated slides. Sections were dewaxed in xylene, rehydrated in graded ethanol, washed in water followed by phosphate-buffered saline (PBS) (0.01 M NaH 2 PO 4 H 2 O, 0.01 M Na 2 HPO 4 , 0.15 M NaCl, pH 7.2), and blocked for endogenous peroxidase (3% H 2 O 2 in PBS) for 5 min at room temperature. Antigen retrieval was performed by pressure cooking for 10 min in 0.01 mM of sodium citrate pH 6. Non-specific binding was blocked by incubating the sections in a solution of 10% FBS diluted in PBS (FBS-PBS) for 30 min at room temperature. Subsequently, the tissue sections were incubated with the primary antibody [Mouse Anti-Human Complex I (NADH dehydrogenase), 19 kDa subunit GRIM-19 monoclonal antibody, MitoScience LLC] diluted at 1:200 overnight at a temperature of 4˚C and rabbit anti-human acetyl p53 (Lys320) (Upstate Lake Placid, NY, USA). Signal was detected with the Dako EnVision System, HRP (DAB) (K4011, Dako A/S, Denmark). Tissue sections were counterstained in aqueous hematoxylin, this followed by sequential dehydration using graded ethanols and xylene prior to mounting and cover slipping.
Results
Gene expression. We evaluated 10 paired tumor samples of cervical cancer patients before and after seven days of HV treatment at a transcriptome level employing Codelink Human Whole Genome Microarrays (each pre-treatment biopsy was hybridized against its post-treatment sample). After gene filtering as described in Patients and methods, we obtained 10,342 genes, which were then analyzed by significance analysis of microarrays (SAM), obtaining 964 signi-ficant up-regulated genes with a FDR <5% and none downregulated at this threshold. This gene list was uploaded onto WebGestalt, to retrieve its KEGG-associated biochemical pathways (Table I ). The two pathways possessing the highest number of up-regulated genes comprised the ribosome protein (RP) and the oxidative phosphorylation (OXPHOS) pathways (Tables II and III) , followed by the following cancerrelated pathways: mitogen activated protein kinase (MAPK) signaling, tight junction, adherens junction, actin cytoskeleton, cell cycle, focal adhesion, apoptosis, proteasome, Wnt signaling, and antigen processing and -presentation pathways, among others. The full list of these genes can be found at: http://www.ncbi.nlm.nih.gov/geo/info/linking.html (GEO Submissions GSE8604).
Epigenetic silencing of genes by DNA methylation and histone deacetylation participates in the molecular pathogenesis of the malignant state, therefore, it can be hypothesized that silenced genes in primary cervical cancer can be re-expressed by epigenetic therapy and therefore, the resulting expression profile of the epigenetically treated tumors would group with those found down-regulated in untreated tumors. To probe our hypothesis, we decided to compare the expression profile we obtained against the expression profile obtained from an unrelated microarray study performed in a similar population of untreated cervical cancer patients (15) . Thus, we evaluated them by hierarchical clustering as three different expression profiles: the profile from this study (HV), the up-regulated (Up-CC) and the downregulated (Down-CC) in a previous report (15) . This initial comparison indicated that there is clustering between HV and ONCOLOGY REPORTS 25: 399-407, 2011 Table I . Pathways with highest number of up-regulated genes. 
LTM, leukocyte transendothelial migration; PI3K, phosphatidylinositol signaling system; CCRI, cytokine-cytokine receptor interaction; KEGG, Kyoto Encyclopedia of Genes and Genomes.
- Table II . Genes from the ribosomal protein pathway. 
the Down-CC profiles. Fig. 1 shows the extent of coincident individual genes shared in these two sets which are listed in Table IV . Further, the expression profiles of these three set of genes were analyzed in terms of biological processes at gene ontology (GO) entities which were considered for our analysis only if adjusted p-values were <0.01. Fig. 2 shows the number of genes associated to biological processes, Down-CC are more alike with HV than those intrinsically up-regulated in primary tumors.
Validation by quantitative RT-PCR. NDUFA13 was upregulated, hence, its level of expression, was evaluated by RT-PCR and immunohistochemistry. There was a tight correlation between the microarray data of this gene with its protein level as with the RNA expression of this gene (Fig. 3a) , as well as with its protein as evaluated by immunohistochemistry in the four cases analyzed. A representative case is shown in Fig. 3b . Furthermore, it has been previously demonstrated that HDAC inhibitors not only exert a transcriptional effect, but they are also able to acetylate a number of proteins such as p53; hence, we performed an immunohistochemistry analysis in four patients. Results indicated that all four cases analyzed had increased acetylated p53 at lysine 320. Fig. 4 depicts a representative case. Table III . Genes from the oxidative phosphorylation pathway. 
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Discussion
The rationale for utilizing epigenetic drugs (DNA methylation and HDAC inhibitors) for cancer treatment has relied on the thought that reversing epigenetic aberrations would turn-on tumor suppressor genes and consequently exert antitumor effects. Most of this knowledge has been generated at the level of individual genes by candidate-gene approach, however, it has been proposed that an epigenomic reactivation screening strategy that combines treatment of cancer cells in vitro with DNA methyltransferase and/or histone deacetylase inhibitors, followed by global gene expression analysis using microarrays to identify up-regulated genes seems to be most effective when complemented by microarray analyses to identify genes repressed in primary tumors. Epigenomic reactivation screening has a number of key advantages over direct analysis of cancer-associated DNA methylation changes; most notably, it directly identifies genes in which epigenetic changes lead to altered gene expression. Nevertheless, this kind of analyses has only been performed in cell lines. For solid tumors, the only information regarding the effects on the cancer transcriptome of HV comes from our study in breast cancer, however, the information provided there is limited as only a single pair of pre and post-treatment sample could be analyzed (12) .
Among 10,226 genes that underwent 2-fold over or underexpression, 964 were significantly overexpressed. Functional analysis of these genes underscore that the two pathways that had the greatest number of genes up-regulated were genes coding for ribosomal proteins (38 genes) and oxidative phosphorylation pathway (34 genes). This result is in agreement with our previous study in breast cancer tumors analyzed in a similar manner (12) .
Ribosomal proteins are integral components of the basal cellular machinery involved in protein synthesis. Various individual ribosomal proteins and also translation, initiation, and elongation factors have been found to play roles in regulating cell growth, transformation, and death, giving rise to increasing speculation that components of the translational apparatus can act as multifunctional proteins (18, 19) . The most Table IV . Genes up-regulated by hydralazine-valproate and found down-regulated in cervical cancer patients. In multiple clusters S100A4 S100 calcium binding protein A4 S100A9 S100 calcium binding protein A9 SBDS Shwachman-Bodian-Diamond syndrome SERP1 Stress-associated endoplasmic reticulum protein 1 SHC1 SHC (Src homology 2 domain containing) transforming protein 1 compelling suggestion concerning the ribosomal protein role in cancer derives from a study in which several hundred lines of zebra fish (Danio rerio), each heterozygous for a recessive embryonic lethal mutation, were generated and screened for lines that displayed early mortality and/or gross evidence of tumors. The authors identified 12 lines with elevated cancer incidence; surprisingly, 11 of the 12 lines were each heterozygous for a mutation in a different ribosomal protein (RP) gene. These data led authors to suggest that many RP genes may act as haplo-insufficient tumor suppressors (20) .
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Interestingly, nine of these 11 genes (S7, S8, S15a, L7, L13, L23a, L35, L36, and L36a) were up-regulated in cervical cancer tumors, as shown in Table II . Further, in humans there is a possible association of mutations in one particular RP gene with cancer: approximately 25% of both sporadic and familial cases of Diamond-Blackfan anemia (DBA) are associated with a rpS19 mutation (21) , and this syndrome includes an increased risk of developing malignancies (22, 23) . Recent data demonstrate that in addition, RPS19 deficiency leads to co-down-regulation of multiple ribosomal protein genes, as well as down-regulation of the genes involved in transcription, translation, and expression changes for multiple cancer-related genes, which suggests a molecular basis for increased risk for malignancy in these patients (24) . Thus, the current findings in cervical cancer patients treated with epigenetic drugs clearly indicate the need for analyzing the role of RP in the molecular pathogenesis of this malignancy. The OXPHOS system consists of a respiratory chain, the adenosine triphosphate (ATP) synthase, and several mitochondrial-membrane metabolite transporters. The respiratory chain is organized in four multiprotein complexes, as well as the ATP synthase. Individual subunits are encoded by both the mitochondrial and the nuclear genome. Defects in the OXPHOS system result in devastating diseases, and in recent years its role in cancer has begun to be studied (25) . For example, the gene codifying the nicotinamide adenine dinucleotide (NADH) dehydrogenase (ubiquinone) 1 · subcomplex 13 is known to be down-regulated in basal cell carcinomas (26) . This gene, also denominated NDUFA13 or GRIM19, was initially identified as a pro-apoptotic gene mediating retinoid antitumor effects and indispensable for proper assembling and functioning of complex I of respiratory chain (27) ; its down-regulation has also been found in doxorubicin-resistant A431 cells (28) . Further, recent studies ONCOLOGY REPORTS 25: 399-407, 2011 Table IV. Continued. - have pointed out the importance of the OXPHOS pathway in carcinogenesis and resistance to cancer therapy (28, 29) , and it has been suggested that loss of cell dependence on oxidative metabolism is an important factor in tumor development. In this line, it has been reported that drug-resistant tumors exhibit low oxidative phosphorylation and high glycolysis (30) . Furthermore, it has been demonstrated that oxidative phosphorylation, and possibly increased oxidative phosphorylation, plays a crucial role in Bax and Bak activation and cell death (31) . A further analysis of metabolic pathways related to energy production in terms of gene ontology (Fig. 5 ) remarks on the fact that HV treatment up-regulates a higher number of genes participating in ATP synthesis, coupled electron transport, oxidative phosphorylation, electron transport and generation of precursor metabolites and energy, as compared to normal cervix and cervical carcinoma, in fact, the two first classes of genes are absent in cervical cancers suggesting the malignant cells tend to have a decreased 'energetical' function which could help tumors to evade apoptosis. Herein, we demonstrated that the epigenetic drugs tested are able to up-regulate a significant number of genes belonging to this pathway suggesting that hydralazine and valproate change tumor metabolism from anaerobic glycolysis to oxidative phosphorylation, which could restore the cells' sensitivity to programmed cell death. Nevertheless, this statement is only hypothetical and needs to be further studied.
Currently, there is no information on whole genome transcriptional changes induced in solid tumors by epigenetic agents; however, we have previously compared the pathways in regard to the number of genes up-regulated in primary colon primary cancers resistant to therapy against our previous data in the colon carcinoma cell line SW480 treated with HV. As reported (32) we found a mirror image on the expressed genes in each of the pathways analyzed suggesting that epigenetic agents can revert the transcriptional signature associated with chemoresistance. Current data on transcriptional changes induced in cancer cell lines by epigenetic agents indicate that not all up-regulated genes have CpG islands in their promoters and theoretically silenced by epigenetic mechanisms, but that gene up-regulation in a proportion of them is secondary of pathway activation. As shown in Table IV , 40% of up-regulated genes by HV coincident with the downregulated in primary cervical tumors have CpG islands.
Finally, current evidence suggests that the antitumor effects of HDAC inhibitors depend not only on transcriptioninduced changes in cancer-related genes, but also on the acetylation of transcription factors and other proteins (33) . We also show here, that as observed in cell lines (34, 49) , this indeed does occur in the clinical setting, as we found an increase in p53 immunostaining with an antibody against the acetylated 320 lysine of p53. Acetylation at this residue is needed for the HDAC inhibitor-induced apoptotic effect (35) .
In summary, the fact that the overall effects of valproate and other HDAC inhibitors alone or with DNA methylation inhibitors on cells can be the induction of cell differentiation, arrest of proliferation, apoptosis, antiangiogenesis, anti-metastasis or reversion of resistance argues towards a mechanism involving changes in the expression of hundreds of genes that in turn may disrupt the 'malignant homeostasis'. Such an effect could be potentiated when these agents are administered along with other cytotoxics and radiation. Nevertheless, a detailed analysis of the changes induced by hydralazine and valproate in each of these pathways is mandatory to better understand its antitumor effects and for developing predictive tools for response and treatment individualization.
